<DOC>
	<DOCNO>NCT01318512</DOCNO>
	<brief_summary>This observational , prospective , multicenter study describe mean dose Mircera ( methoxy polyethylene glycol-epoetin beta ) hemoglobin level patient chronic kidney disease . Patients dialysis naive , receive erythropoiesis stimulate agent treatment . Data collect 10 month .</brief_summary>
	<brief_title>An Observational Study Mircera ( Methoxy Polyethylene Glycol-epoetin Beta ) Patients With Chronic Kidney Disease Not On Dialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Adults patient , &gt; /=18 year age Presence chronic kidney disease ( Stage 34 ) Participation another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>